Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T22:10:50.098Z.
Calculation as of: 2026-10-06T22:10:50.098Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9a6fb48ec682e3cf9a2a3de0b7f1962f0667ac92b413acd908fc1cfb112ec24a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$48.89M
EBITDA Yield
N/A
TTM Avg
11.25%
3Y Avg
14.93%
5Y Avg
13.84%
Market Cap
$49.25M
EBITDA Yield
N/A
TTM Avg
0.84%
3Y Avg
0.84%
5Y Avg
0.84%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $48.53M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 0.89% | 5.54% | 4.70% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A | N/A | N/A | N/A |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 11.25% | 14.93% | 13.84% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 0.84% | 0.84% | 0.84% |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $49.71M | N/A | 3.11% | 2.71% | 2.71% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A | 0.59% | 0.59% | 0.59% |
| biote Corp. (BTMD)vs › | $50.28M | 11.09% | 20.03% | 16.76% | 21.84% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
